Transient akathisia after the SARS-Cov-2 vaccine

Meagen R. Salinas; Marisara Dieppa

Clinical Parkinsonism & Related Disorders (Jan 2021)

Transient akathisia after the SARS-Cov-2 vaccine

Meagen R. Salinas,
Marisara Dieppa

Affiliations

Meagen R. Salinas: University of Texas Southwestern Medical Center, Dallas, TX, USA; Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, USA; Corresponding author at: UT Southwestern Medical Center, Department of Neurology, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Marisara Dieppa: University of Texas Southwestern Medical Center, Dallas, TX, USA

Journal volume & issue: Vol. 4
p. 100098

Abstract

Read online

We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus.

Published in Clinical Parkinsonism & Related Disorders

ISSN: 2590-1125 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://www.journals.elsevier.com/clinical-parkinsonism-and-related-disorders

About the journal

Abstract

Keywords